$BIOC Let me remind you all. Their Q3 revenue incrased over 4 times comapred to last year and last week update confirmed that they had already met Q3 revenue when there was half way to go in Q4. So Q4 revenue will be crazy as testing continues and will continue well into 2021. Besides that, they are becoming major player in liquid biopsy market so this company has shown ability to develop very fast in 2020 and in near future. There are also some collabs going on related to Covid products. Analysts just updated their PT and it is 20 bucks: tipranks.com/stocks/bioc/fo...
  • 3
3 Likes